LogicBio Therapeutics Q3 EPS $(0.48) Up From $(4.03) YoY

LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.48) per share. This is a 88.09 percent increase over losses of $(4.03) per share from the same period last year.

Benzinga · 11/12/2019 14:05

LogicBio Therapeutics (NASDAQ:LOGC) reported quarterly losses of $(0.48) per share. This is a 88.09 percent increase over losses of $(4.03) per share from the same period last year.